MarketPulse

vascular devices

2 articles
BenzingaBenzinga··Na

LeMaitre Vascular Crushes Q1 Targets, Raises Full-Year Guidance Amid Strong Momentum

LeMaitre Vascular reports 11% organic Q1 growth, expanding margins, and raises 2026 guidance on strong Artegraft performance and geographic expansion.
LMATvascular devicesrevenue growth
GlobeNewswire Inc.GlobeNewswire Inc.··Na

LeMaitre Vascular to Present at Five Major Healthcare Investment Forums in March

LeMaitre Vascular will present at five major healthcare investment conferences in March 2026, engaging with institutional investors and analysts about corporate strategy and growth opportunities.
LMATinvestor conferencesvascular devices